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Abstract 
Stand-alone integrated MEA system were developed and tested to investigate the effect of toxic compounds on 
network neural activities during chronic recordings. The system, consisting of specifically designed MEA aim to 
receive microfluidic organic substances and to communicate using wireless technology with the computer device. 
The system has been tested with several types of 2D and 3D neuronal cultures. The electrophysiological data are 
processed by NeuroSpy, a modify version of SpyCode. The software developed is able to analyze the basal activi-
ty, drug and stimulation evoked response. 
1 Background 
"Cell biochips" containing engineered tissue in-
terconnected by a microfluidic network allows the 
control of microfluidic flows for dynamic cultures by 
continuously feeding of nutrients and waste removal. 
Thus, these types of systems can enhance functionali-
ty of cells by mimicking the tissue architecture com-
plexities when compared to in vitro analysis, but at the 
same time present a more rapid and simple process 
when compared to in vivo testing procedures. To date, 
one of the most promising tools for neuropharmaco-
logical functional tests is the Micro-Electrode Array 
(MEA). MEAs have been applied to study multiple 
aspects of electrically excitable cells and to explore 
the pharmacological and toxicological effects of nu-
merous compounds on spontaneous activity of elec-
trogenic cells (A. Novellino, T. J. Shafer et al. 2011). 
As a complementary tool to standard MEA platforms, 
we are developing a novel stand-alone system able to 
acquire, stimulate and feed the cultures. This new ap-
proach will keep the cultures inside the incubator 
providing a useful tool for chronic long-term record-
ings, with the possibility to continuously submit expo-
sure to drugs or chemicals.  
2  Methods and Statistics 
We have developed a small-volume in vitro sys-
tem in which neural cells/tissues can be cultivated in 
four separate porous membrane microchambers. 
These are connected by microchannels with the pres-
ence of a MEA in each well (Fig. 1). Each MEA, in 
this configuration, is composed by 8 recording elec-
trodes plus two additional electrodes which can be 
used for electrically stimulating the cultures through 
the STG4002 stimulator (MCS). Electrophysiological 
activities recorded from the 4 integrated MEAs are 
transmitted through the Wireless System W32 (devel-
oped for in vivo applications by Multi Channel Sys-
tems, Reutlingen, Germany) and adapted to this par-
ticular in vitro application. 
The wireless headstage is directly linked to the chip 
and integrated into the main body of the system. A 
specific micro-peristaltic pump, developed in order to 
feed the culture during the incubating period, is con-
trolled by a dedicated software to operate it via Blue-
tooth or wireless mode. 
We developed a modified version of the Spycode 
software (Bologna et al. 2010), called NeuroSpy (Fig. 
2), to perform the analysis of electrophysiological data 
of neuronal cultures, acquired by MEAs. NeuroSpy 
allows performing basic and high precision offline 
analyses . Moreover, the software is able to perform a 
specific type of analysis aim to study the behaviour of 
the 2D or 3D neural cultures, as a result of both chem-
ical and electrical stimulation. 
Fig. 1. Complete system: MEA chip, wifi system, perfusion pump. 
Fig. 2. Analysis software: Neurospy interface. 
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3 Results 
In the first series of experiments, we could record 
the electrophysiological signals from several types of 
cells, with the aim at testing the system performance.  
Basically, the behaviour of the system has been 
studied with 2D and 3D cells structure, derived from 
human sphere stem cells, rat brain cortex, rat hippo-
campus slices and dissociated cells. 
Fig.3 shows a network burst activity, recorded 
from a 3D neural network (derived from H9 or iPs 
stem cells), through the raw data and a raster plot.
Fig.4 Shows the Mean Firing Rate and the Mean
Bursting Rate from dissociating cells from rat brain 
cortex. Fig.5 shows the ISI histogram relative to the 
same experiment of Fig.4 and Fig.5.
Fig. 3. Electrophysiological activity from a representative experi-
ment of a neural network derived from H9 cells. Top panel, raw data 
recorded from one electrode. Bottom panel, raster plot depicting the 
activity from the 32 channels of the array. 
Fig. 4. MFR and MBR from a representative experiment of a neural 
network derived from rat brain cortex. Left panel, Mean Firing Rate 
(spikes/sec). Right panel, Mean Bursting Rate (Bursts/Min). 
Fig. 5. ISI histogram from a representative experiment of a neural 
network derived from rat brain cortex
4 Conclusion
These human surrogate integrated Biochips will 
enable the determination of toxicological profiles of 
new drug candidates. In addition, the developed sys-
tem will provide scientists with alternative ways to 
test more thoroughly new drugs or chemicals. It will 
also help to understand the process that causes an or-
ganism to react and adapt when exposed to drugs over 
a long timescales. 
Moreover, the system will provide scientists with 
a new independent device able to reduce contamina-
tions factors, due to interactions between the organic 
components and external agents, thanks to the feed-
ing, recording and stimulating remote wireless con-
trol. Scientists will be able to monitor the culture since 
the first day in vitro, without the risk of expose them 
to an excessive stress due to the behaviours changing. 
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